en · de · es · fr · pt
semax-notes.peptides9000.com › Blog › Semax Background And Mechanism — Explained

Semax Background And Mechanism — Explained

By Editorial Desk · published 2026-07-13 · last reviewed 2026-08-01 · Blog

heptapeptide raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.

Semax Background And Mechanism

The proposed mechanism centres on neurotrophic signalling rather than direct receptor activation. Semax is reported to increase expression of brain-derived neurotrophic factor and nerve growth factor in several brain regions, and to shift the balance between excitatory and inhibitory neurotransmitter systems. Interaction with melanocortin receptors has been suggested because of the parent ACTH fragment. Many of these findings come from rodent studies, and the extent to which they translate to human physiology remains an open question.

Scientific literature on semax is unevenly distributed. A substantial share of published work originates from a small number of laboratories in Russia, while independent replication elsewhere is limited. Human data consist mostly of small trials with short follow-up, and several reported outcomes rely on subjective rating scales. Questions about how much intact peptide reaches the central nervous system after nasal administration, and how long it persists there, are still unresolved. The compound is best described as an active research subject rather than a settled pharmacological agent.

Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It was derived from the ACTH(4-10) fragment, a short segment of adrenocorticotropic hormone that lacks the hormonal activity associated with the full-length peptide. Researchers at the Institute of Molecular Genetics in Moscow developed the compound during the 1980s. It has been registered as a pharmaceutical product in Russia and several neighbouring countries, where it is supplied as a nasal solution, and it is also sold internationally as a research chemical.

Semax 的分子背景与结构

研究兴趣主要集中在神经营养因子相关的路径上,包括脑源性神经营养因子与神经生长因子的表达变化。部分实验报告称在特定条件下观察到这些因子的水平上升,但具体信号通路和剂量依赖关系仍未完全厘清。多数公开数据来自细胞模型和动物实验,人体对照研究数量有限。因此,该化合物的作用机制在文献中属于活跃讨论,而非已经确立的定论。

Semax 是一种人工合成的七肽,氨基酸序列为 Met-Glu-His-Phe-Pro-Gly-Pro,单字母缩写记作 MEHFPGP。它被归类为促肾上腺皮质激素片段 ACTH(4-10) 的结构类似物,但并不天然存在于生物体内。母体片段 ACTH(4-10) 的序列为 Met-Glu-His-Phe-Arg-Trp-Gly,Semax 替换了中间两个残基,并在羧基端延长了 Pro-Gly-Pro 三肽。这种延长被普遍认为能提升分子对肽酶的耐受性。

Semax at a glance

PropertyValueNotes
Molecular formulaC37H51N9O10SCalculated for the free peptide
Molar mass813.9 g/molAnhydrous free base
Peptide classSynthetic heptapeptideACTH(4-10) analogue
Parent fragmentACTH(4-10)Adrenocorticotropic hormone segment
Developmental originInstitute of Molecular Genetics, MoscowWork began in the 1980s

Semax Structure and Research Background

Laboratory work points toward modulation of neurotrophic signaling, particularly expression of brain-derived neurotrophic factor and nerve growth factor in hippocampal tissue. Studies also describe effects on monoamine turnover, inflammatory mediators, and oxidative markers. These observations come mainly from animal models and cultured cells, so the causal chain in humans is not firmly established. Whether the reported molecular changes translate into measurable clinical benefit is an open question. Reviews generally present the mechanism as plausible rather than demonstrated.

Clinical evidence consists largely of small trials with modest sample sizes, often without independent replication. Reported endpoints include cognitive scores, recovery after stroke, and visual function, but study designs vary widely and few trials meet contemporary reporting standards. Systematic reviewers have noted a high risk of bias in several of these reports. No large multicenter trial conducted outside Russia has been published. The compound is therefore best described as investigational in most jurisdictions, with its clinical role still unresolved.

Related pages on this site

Background and Development History

Regulatory status varies sharply by country. Semax is registered for medical use in Russia, where it appears in formularies as a nasal solution, and it also holds registration in a small number of neighbouring states. It has no approval from the United States Food and Drug Administration or the European Medicines Agency, and it is not a scheduled controlled substance in most jurisdictions. Elsewhere it circulates mainly as laboratory material, so purity documentation comes from suppliers rather than from a national pharmacopoeia.

Semax is a synthetic peptide created in the Soviet Union during the early 1980s by researchers working in Moscow. It was built from the short adrenocorticotropic hormone fragment known as ACTH(4-10), and the chain was then extended with three additional amino acids. The resulting molecule was named semax and entered clinical use in Russia in 1994. It is generally described as a nootropic and neuroprotective agent rather than as a hormone analogue.

Semax Origin and Molecular Structure

Pharmacological accounts link semax to melanocortin signalling and to modulation of neurotrophic factor expression, particularly brain-derived neurotrophic factor and nerve growth factor. Much of this evidence comes from rodent studies using intranasal delivery, a route chosen because it allows peptides to reach the central nervous system with limited systemic exposure. Whether the same mechanisms operate in humans at comparable magnitude remains an open question. The precise receptor or receptors responsible for the reported behavioural and neuroprotective effects have not been conclusively identified.

Clinical reports describe use in ischaemic stroke, transient ischaemic attack, optic nerve conditions, and cognitive complaints, but most of these studies are small and were conducted in a single region. Systematic reviews have generally described the evidence base as limited in size and variable in methodological quality. Randomised controlled data suitable for international regulatory assessment are scarce. As a result, major treatment guidelines outside Russia do not include the peptide, and interest in it remains largely research-driven rather than routine clinical.

Semax Peptide Structure and Origin

The compound was developed during the 1980s at the Institute of Molecular Genetics in Moscow as part of research on fragments of adrenocorticotropic hormone. Early work examined short ACTH-derived sequences that retained neurotrophic effects while lacking the endocrine activity of the full hormone. Semax entered clinical use in Russia during the 1990s, where it received registration for several neurological indications. Outside that region it remained primarily a laboratory research material rather than an approved therapeutic. English-language literature on it grew more slowly and frequently cited the original Russian studies.

Terminology around the compound varies by source. It appears in catalogues and papers as Semax, as the heptapeptide ACTH(4-7)-Pro-Gly-Pro, and under various alphanumeric laboratory codes used by individual suppliers. These names refer to the same sequence but may imply different salt forms, purity grades, or counter-ions. Peptide databases usually list the free base mass, while product descriptions sometimes report acetate or trifluoroacetate salts with a different formula weight. Because naming conventions for research peptides are not standardised across vendors, checking the declared sequence and measured mass is more reliable than relying on a trade name alone.

Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its design combines the ACTH(4-7) core fragment with a C-terminal Pro-Gly-Pro extension, a modification intended to improve stability and prolong activity. The molecule is hydrophilic, carries no lipid chains or glycosylation, and has a theoretical mass just over 810 daltons in its free form. All seven residues are proteinogenic amino acids, so no non-natural building blocks appear in the backbone. A free N-terminal methionine and C-terminal proline define the unmodified parent peptide.

Reference notes

==== Chain length ==== A common means of expressing the length of a chain is the degree of polymerization, which quantifies the number of monomers incorporated into the chain. As with other molecules, a polymer's size may also be expressed in terms of molecular weight. Since synthetic polymerization techniques typically yield a statistical distribution of chain lengths, the molecular weight is expressed in terms of weighted averages. The number-average molecular weight (Mn) and weight-average molecular weight (Mw) are most commonly reported. The ratio of these two values (Mw / Mn) is the dispersity (Đ), which is commonly used to express the width of the molecular weight distribution. The physical properties of polymer strongly depend on the length (or equivalently, the molecular weight) of the polymer chain. One important example of the physical consequences of the molecular weight is the scaling of the viscosity (resistance to flow) in the melt. The influence of the weight-average molecular weight (

== Production == Aerated chocolate containing large bubbles is produced via two methods. In the first, melted chocolate is put under a vacuum, where it foams up. As the chocolate cools, and the fats within the chocolate set, the foam structure remains. Sometimes gases such as carbon dioxide are introduced into the mixture before it is placed under the vacuum. Although the method easily permits inclusions such as nougat or nuts, the production is labor-intensive and difficult to keep hygienic. As a result, the second method is more frequently used: working gases into liquid, tempered chocolate under high pressure. Carbon dioxide is mainly used, although others include nitrous oxide. Air is avoided, as oxygen causes chocolate to become rancid. Any gases that do not dissolve are dispersed as bubbles through the chocolate using a beater. As the chocolate is released from the high pressure conditions, the bubbles expand, foaming the product; through this, the amount of pressure directly impacts bubble size. The setting chocolate is deposited in a moulded shell, after which the set interior is capped with liquid tempered chocolate. Factors that affect bubble size include qualities of chocolate, such as viscosity and the rate of setting. The ingredients used, such as emulsifiers and milk fats also impact bubble size; other factors include type of gas and how much pressure is applied. Micro-aerated chocolate is created using the method of beating gases in under high pressure.

== Background == During the early 19th century, a diverse group of Sotho-, Nguni- and Tswana-speaking tribes settled in the Caledon River region. The latter two, which formed the minority of the population, were gradually assimilated by the culturally dominant Sotho. King Moshoeshoe I united the various Sotho-speaking chieftainships into a single nation during a period of political turbulence known as Lifaqane. He transformed the denigratory exonym of Sotho into the name of the nascent Basuto nation. In 1833, missionaries from the Paris Evangelical Missionary Society began setting their outposts in Basuto lands following Moshoeshoe's invitation. They promoted a combination of Christianity, Western civilization, and commerce. They saw Basuto customs linked to obligatory labor and the dependence of the population on their chiefs as evil. They sought to undermine them by promoting private property, the commodization of production and closer economic ties with European settlers. In the 1820s, the Basuto faced cattle raids from the Koranna and first encountered horses and guns in a combat setting. They obtained horses and guns of their own, and began stockpiling gunpowder. By 1843, Moshoeshoe had accumulated more horses and guns than any other chieftain in South Africa, but the guns were outdated flintlocks, which had flooded the South African market after the introduction of percussion lock muskets.

The bonnet is usually a copper shell with soldered brass fittings. It covers the diver's head and provides sufficient space to turn the head to look out of the glazed faceplate and other viewports (windows). The front port can usually be opened for ventilation and communication when the diver is on deck, by being screwed out or swung to the side on a hinge. The other lights (another name for the viewports) are generally fixed. Viewports were glass on the early helmets, with some of the later helmets using acrylic, and are usually protected by brass or bronze grilles. The helmet has fittings to connect the air line and the diver's telephone. All except the earliest helmets include a non-return valve where the airline is connected, which prevents potentially fatal helmet squeeze if the pressure in the hose is lost. The difference in pressure between the surface and the diver can be so great that if the air line is cut at or near the surface and there is no non-return valve, the diver would be partly squeezed into the helmet by the external pressure, and injured or possibly killed. Helmets also have a spring-loaded exhaust valve which allows excess air to leave the helmet. The spring force is adjustable by the diver to prevent the suit from deflating completely or over-inflating and the diver being floated uncontrollably to the surface. Some helmets have an extra manual valve known as a spit-cock, which can be used to vent excess air when the diver is in a position where the main exhaust can not function correctly.

Regarding applicability to a range of HPLC flow rates, the signal level of analytes by APPI has been observed to saturate and even decay at higher solvent flow rates (above 200 μl/min), and therefore, much lower flow rates are recommended for APPI than for ESI and APCI. This has been suggested to be due to absorption of photons by the increasing density of solvent molecules., However, this leads to the benefit that APPI can extend to very low flow rates (e.g., 1 μL/min domain) allowing for effective use with capillary LC and capillary-electrophoresis.

Sources: en.wikipedia.org

Reference notes

== Awards == Prix scientifique de la Fondation de France, with André Langaney, 1978 Prix de la Société française de physique, 1985 Le Relictocarabus meurguesianus, and insect discovered in Morocco, was named in her honour.

Internal aldimine formation: First, the ε-amino group of Lys258 forms a Schiff base linkage with the aldehyde carbon to generate an internal aldimine. Transaldimination: The internal aldimine then becomes an external aldimine when the ε-amino group of Lys258 is displaced by the amino group of aspartate. This transaldimination reaction occurs via a nucleophilic attack by the deprotonated amino group of Asp and proceeds through a tetrahedral intermediate. As this point, the carboxylate groups of Asp are stabilized by the guanidinium groups of the enzyme's Arg386 and Arg292 residues. Quinonoid formation: The hydrogen attached to the α-carbon of Asp is then abstracted (Lys258 is thought to be the proton acceptor) to form a quinonoid intermediate. Ketimine formation: The quinonoid is reprotonated, but now at the aldehyde carbon, to form the ketimine intermediate. Ketimine hydrolysis: Finally, the ketimine is hydrolyzed to form PMP and oxaloacetate. This mechanism is thought to have multiple partially rate-determining steps. However, it has been shown that the substrate binding step (transaldimination) drives the catalytic reaction forward.

Hydrogen and methane can both be used as alternatives to fossil fuels in internal combustion engines or for power generation. Like MFCs or bioethanol production plants, MECs have the potential to convert waste organic matter into a valuable energy source. Hydrogen can also be combined with the nitrogen in the air to produce ammonia, which can be used to make ammonium fertilizer. Ammonia has been proposed as a practical alternative to fossil fuel for internal combustion engines. Hydrogen technologies Microbial electrosynthesis Microbial fuel cells Microbial electrolysis carbon capture National Science Foundation The University of Queensland Scientific Blogging [1]

Yeast estrogen screen (YES) and Yeast androgen screen (YAS) are in vitro screens that have been developed in order to detect estrogenic and androgenic activities, respectively, of natural and synthetic compounds, mixtures and environmental samples. The test is based on genetically modified yeast cells (Saccharomyces cerevisiae), which contain the gene for the human estrogen or androgen receptor coupled to a reporter gene (e.g. lacZ). Activation of the receptor initiates a cascade of events leading to the expression of the reporter gene product (e.g. β-galactosidase) which converts a substrate (e.g. CPRG) which leads to a measurable color change from yellow to red in the medium. Alternative systems are based on the generation of a luminescence signal. Activating (agonistic) samples can be measured directly; inhibiting (antagonistic) activities are measured as the reduction of color development in the presence of a known activating substance.

Sources: en.wikipedia.org

Notes from published material

=== November === 1 November Amid an ongoing boom in artificial intelligence, the UK hosts the world's first international summit devoted to safely managing the technology. Computer simulations reveal that remnants of a protoplanet named Theia could be inside the Earth, left over from a giant collision in ancient times, which afterwards formed the Moon. Dinkinesh, previously thought to be a single asteroid, is revealed by NASA's Lucy probe to in fact be a binary pair. 5 November – A new record high efficiency of 33.9% is reported for a silicon-perovskite tandem solar cell. This also surpasses the Shockley-Quieser theoretical limit of 33.7% of single junction solar cells for the first time. 6 November – Scientists release the first connectome of neuropeptide signaling in an animal nervous system (C. elegans). On 1 November, a functional atlas of signal propagation in 23,433 pairs of neurons across the worm's head by direct optogenetic activation is published. On 17 November, the development of fluorescent neuropeptide sensors is reported. 7 November – A study finds that "catastrophic ecosystem collapse" of UK forests is likely within the next 50 years, due to a wide range of factors. 8 November – In 10 studies, researchers of the Sc2.0 project report yeast with a half-synthetic genome. 9 November – Surgeons report the first human eye transplant; the patient did not regain sight in the transplanted eye. 10 November – A new scalable technique for carbon nanotube-based MOSFETs is demonstrated.

====== Order Proboscidea ====== Family Elephantidae (Elephants) Elephas maximus, Asian elephant, (2015, 2024) † Mammuthus primigenius, Wooly mammoth, (2015) Loxodonta africana, African bush elephant, (2009, 2024) Loxodonta cyclotis, African forest elephant, (2018)

=== Gold nanoparticles in wound healing applications === In 2016, a paper published in the Journal of Biomaterials Application, titled "Collagen/gold nanoparticle composites: A potential skin wound healing biomaterial," discussed that in vivo studies of gold nanoparticle and collagen composites demonstrated high wound closure percentage, reduced inflammatory response, increased neovascularization, and granulation tissue formation. It was also shown that these improvements in healing effects increase proportionally with the amount of gold nanoparticles worked into the collagen scaffold. In another study, the effect of spherical gold nanoparticles as a wound healing agent was tested in rat model by coupling gold nanoparticles with photobiomodulation therapy (PBMT). PBMT is a light stimulated therapy that is used for wound healing treatment without any significant temperature changes. The coupling of gold nanoparticles and PBMT increase the wound contraction rate by approximately 1.25 times than the control group that received no gold. nanoparticle treatment.

In 2021, Pansino hosted the HBO Max series Baketopia where contestants competed in a bake-off to win up to $10,000; her hosting work on the show received praise and she also executive produced several episodes. In November 2024, Pansino started her own podcast series called the "Rodiculous Podcast", where she has interviews and conversations with celebrities and fellow YouTubers, with a lot of them being her friends.

The first Neanderthal genome sequence was published in 2010, and strongly indicated interbreeding between Neanderthals and early modern humans. Neanderthal-derived genes descend from at least 2 interbreeding episodes outside of Africa: one about 250,000 years ago and another 40,000 to 54,000 years ago. Interbreeding also occurred in other populations which are not ancestral to any living person. An individual whose ancestry lies beyond sub-Saharan Africa may carry about 2% of Neanderthal DNA. Sub-Saharan Africans can carry Neanderthal DNA presumably descending from back migration (the interbreeding population having migrated back to Sub-Saharan Africa). In all, approximately 20% of the Neanderthal genome appears to have survived in the modern human gene pool. This Neanderthal DNA is derived primarily from the children of female modern humans and male Neanderthals. Due to their low population and proliferation of deleterious mutations, many Neanderthal genes were probably selected out of the modern human gene pool (negative selection). Similarly, a large portion of surviving introgression appears to be non-coding ("junk") DNA with few biological functions. Some Neanderthal-derived genes, nonetheless, may have functional implications related to metabolism, brain function, and skeletal and muscular development. Some genes may have helped immigrating modern human populations acclimatise faster, such as genes related to immune response. The genetic evidence suggests that the interbreeding mainly took place between Neanderthal men and modern human women.

Sources: en.wikipedia.org

Frequently asked questions

What is semax derived from?

Semax is based on the ACTH(4-10) fragment, a seven-amino-acid segment of adrenocorticotropic hormone. The synthetic peptide retains the core sequence while removing regions associated with endocrine activity. This modification is intended to isolate effects on the nervous system.

Is semax approved as a medicine?

It is registered for clinical use in Russia and a few other countries, typically as a nasal drop formulation. It does not hold approval from the United States Food and Drug Administration or the European Medicines Agency. Outside those markets it is generally handled as a research chemical.

Why is much of the research published in Russian?

The compound was developed in Moscow and the earliest studies were conducted there, so the primary literature is largely in Russian-language journals. Translation and indexing have been incomplete, which limits access for outside researchers. Independent groups have since published some work, but the total volume remains modest.

Semax 是天然存在的物质吗?

不是。Semax 是完全人工合成的七肽,自然界中没有对应的已知肽段。它的设计灵感来自促肾上腺皮质激素片段 ACTH(4-10),但序列经过了替换和延长。

Network